Vancomycin Use in Children and Neonates across Three Decades: A Bibliometric Analysis of the Top-Cited Articles
Vancomycin is frequently prescribed in pediatrics, especially in intensive care unit settings, to treat Gram-positive bacterial infections. This work aims to collect the top-cited articles of pediatric and infectious diseases areas to gather the current evidence and gaps of knowledge on the use of v...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/10/10/1343 |
_version_ | 1797513464352079872 |
---|---|
author | Chiara Minotti Elisa Barbieri Carlo Giaquinto Daniele Donà |
author_facet | Chiara Minotti Elisa Barbieri Carlo Giaquinto Daniele Donà |
author_sort | Chiara Minotti |
collection | DOAJ |
description | Vancomycin is frequently prescribed in pediatrics, especially in intensive care unit settings, to treat Gram-positive bacterial infections. This work aims to collect the top-cited articles of pediatric and infectious diseases areas to gather the current evidence and gaps of knowledge on the use of vancomycin in these populations. The most relevant journals reported in the “pediatrics” and “infectious diseases” categories of the 2019 edition of Journal Citation Reports were browsed. Articles with more than 30 citations and published over the last three decades were collected. A bibliometric analysis was performed and 115 articles were retrieved. They were published in 21 journals, with a median impact factor of 4.6 (IQR 2.9–5.4). Sixty-eight of them (59.1%) belonged to “infectious diseases” journals. The most relevant topic was “bloodstream/complicated/invasive infections”, followed by “antibiotic resistance/MRSA treatment”. As for population distribution, 27 articles were on children only and 27 on neonates, most of which were from intensive care unit (ICU) settings. The current literature mainly deals with vancomycin as a treatment for severe infections and antibiotic resistance, especially in neonatal ICU settings. Lately, attention to new dosing strategies in the neonatal and pediatric population has become a sensible topic. |
first_indexed | 2024-03-10T06:16:56Z |
format | Article |
id | doaj.art-1c7fc88997444707b8156a01300ec4eb |
institution | Directory Open Access Journal |
issn | 2076-0817 |
language | English |
last_indexed | 2024-03-10T06:16:56Z |
publishDate | 2021-10-01 |
publisher | MDPI AG |
record_format | Article |
series | Pathogens |
spelling | doaj.art-1c7fc88997444707b8156a01300ec4eb2023-11-22T19:34:41ZengMDPI AGPathogens2076-08172021-10-011010134310.3390/pathogens10101343Vancomycin Use in Children and Neonates across Three Decades: A Bibliometric Analysis of the Top-Cited ArticlesChiara Minotti0Elisa Barbieri1Carlo Giaquinto2Daniele Donà3Division of Pediatric Infectious Diseases, Department of Women’s and Children’s Health, University of Padova, 35100 Padova, ItalyDivision of Pediatric Infectious Diseases, Department of Women’s and Children’s Health, University of Padova, 35100 Padova, ItalyDivision of Pediatric Infectious Diseases, Department of Women’s and Children’s Health, University of Padova, 35100 Padova, ItalyDivision of Pediatric Infectious Diseases, Department of Women’s and Children’s Health, University of Padova, 35100 Padova, ItalyVancomycin is frequently prescribed in pediatrics, especially in intensive care unit settings, to treat Gram-positive bacterial infections. This work aims to collect the top-cited articles of pediatric and infectious diseases areas to gather the current evidence and gaps of knowledge on the use of vancomycin in these populations. The most relevant journals reported in the “pediatrics” and “infectious diseases” categories of the 2019 edition of Journal Citation Reports were browsed. Articles with more than 30 citations and published over the last three decades were collected. A bibliometric analysis was performed and 115 articles were retrieved. They were published in 21 journals, with a median impact factor of 4.6 (IQR 2.9–5.4). Sixty-eight of them (59.1%) belonged to “infectious diseases” journals. The most relevant topic was “bloodstream/complicated/invasive infections”, followed by “antibiotic resistance/MRSA treatment”. As for population distribution, 27 articles were on children only and 27 on neonates, most of which were from intensive care unit (ICU) settings. The current literature mainly deals with vancomycin as a treatment for severe infections and antibiotic resistance, especially in neonatal ICU settings. Lately, attention to new dosing strategies in the neonatal and pediatric population has become a sensible topic.https://www.mdpi.com/2076-0817/10/10/1343vancomycinbibliometric analysistop-cited articlespediatric infectious diseaseschildrenneonates |
spellingShingle | Chiara Minotti Elisa Barbieri Carlo Giaquinto Daniele Donà Vancomycin Use in Children and Neonates across Three Decades: A Bibliometric Analysis of the Top-Cited Articles Pathogens vancomycin bibliometric analysis top-cited articles pediatric infectious diseases children neonates |
title | Vancomycin Use in Children and Neonates across Three Decades: A Bibliometric Analysis of the Top-Cited Articles |
title_full | Vancomycin Use in Children and Neonates across Three Decades: A Bibliometric Analysis of the Top-Cited Articles |
title_fullStr | Vancomycin Use in Children and Neonates across Three Decades: A Bibliometric Analysis of the Top-Cited Articles |
title_full_unstemmed | Vancomycin Use in Children and Neonates across Three Decades: A Bibliometric Analysis of the Top-Cited Articles |
title_short | Vancomycin Use in Children and Neonates across Three Decades: A Bibliometric Analysis of the Top-Cited Articles |
title_sort | vancomycin use in children and neonates across three decades a bibliometric analysis of the top cited articles |
topic | vancomycin bibliometric analysis top-cited articles pediatric infectious diseases children neonates |
url | https://www.mdpi.com/2076-0817/10/10/1343 |
work_keys_str_mv | AT chiaraminotti vancomycinuseinchildrenandneonatesacrossthreedecadesabibliometricanalysisofthetopcitedarticles AT elisabarbieri vancomycinuseinchildrenandneonatesacrossthreedecadesabibliometricanalysisofthetopcitedarticles AT carlogiaquinto vancomycinuseinchildrenandneonatesacrossthreedecadesabibliometricanalysisofthetopcitedarticles AT danieledona vancomycinuseinchildrenandneonatesacrossthreedecadesabibliometricanalysisofthetopcitedarticles |